ReP USP - Resultado da busca

Artigo de periodico
Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells (2016)
Diniz, Mariana O.; Sales, Natiely S.; Silva, Jamile R.; Ferreira, Luís Carlos de Souza
Source: Molecular Cancer Therapeuthics. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Mariana O. et al. Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells. Molecular Cancer Therapeuthics, v. 15, n. 8, p. 1920-1930, 2016Tradução . . Disponível em: https://doi.org/10.1158/1535-7163.MCT-15-0742. Acesso em: 03 maio 2024.
APA
Diniz, M. O., Sales, N. S., Silva, J. R., & Ferreira, L. C. de S. (2016). Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells. Molecular Cancer Therapeuthics, 15( 8), 1920-1930. doi:10.1158/1535-7163.MCT-15-0742
NLM
Diniz MO, Sales NS, Silva JR, Ferreira LC de S. Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells [Internet]. Molecular Cancer Therapeuthics. 2016 ; 15( 8): 1920-1930.[citado 2024 maio 03 ] Available from: https://doi.org/10.1158/1535-7163.MCT-15-0742
Vancouver
Diniz MO, Sales NS, Silva JR, Ferreira LC de S. Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells [Internet]. Molecular Cancer Therapeuthics. 2016 ; 15( 8): 1920-1930.[citado 2024 maio 03 ] Available from: https://doi.org/10.1158/1535-7163.MCT-15-0742
Artigo de periodico
Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors (2013)
Diniz, Mariana O.; Cariri, Francisco A. M. O.; Aps, Luana Raposo de Melo Moraes; Ferreira, Luís Carlos de Souza
Source: Human Gene Therapy. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Mariana O. et al. Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors. Human Gene Therapy, v. 24, n. 10, p. 861-870, 2013Tradução . . Disponível em: https://doi.org/10.1089/hum.2013.102. Acesso em: 03 maio 2024.
APA
Diniz, M. O., Cariri, F. A. M. O., Aps, L. R. de M. M., & Ferreira, L. C. de S. (2013). Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors. Human Gene Therapy, 24( 10), 861-870. doi:10.1089/hum.2013.102
NLM
Diniz MO, Cariri FAMO, Aps LR de MM, Ferreira LC de S. Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors [Internet]. Human Gene Therapy. 2013 ; 24( 10): 861-870.[citado 2024 maio 03 ] Available from: https://doi.org/10.1089/hum.2013.102
Vancouver
Diniz MO, Cariri FAMO, Aps LR de MM, Ferreira LC de S. Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors [Internet]. Human Gene Therapy. 2013 ; 24( 10): 861-870.[citado 2024 maio 03 ] Available from: https://doi.org/10.1089/hum.2013.102
Artigo de periodico
Bicistronic DNA Vaccines Simultaneously Encoding HIV, HSV and HPV Antigens Promote CD8+ T Cell Responses and Protective Immunity (2013)
Santana, Vinicius C.; Diniz, Mariana O.; Cariri, Francisco A. M. O.; Ventura, Armando Morais ; Cunha-Neto, Edécio; Almeida, Rafael R.; Campos, Marco A.; Lima, Graciela K.; Ferreira, Luís Carlos de Souza
Source: PLOS ONE. Unidades: ICB, FM
Subjects: HIV (IMUNOLOGIA), IMUNIDADE, VACINAS VIRAIS (IMUNOLOGIA), LINFÓCITOS T (ANÁLISE), DNA VIRAL (IMUNOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Vinicius C. et al. Bicistronic DNA Vaccines Simultaneously Encoding HIV, HSV and HPV Antigens Promote CD8+ T Cell Responses and Protective Immunity. PLOS ONE, v. 8, n. 8, p. 10 , 2013Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0071322. Acesso em: 03 maio 2024.
APA
Santana, V. C., Diniz, M. O., Cariri, F. A. M. O., Ventura, A. M., Cunha-Neto, E., Almeida, R. R., et al. (2013). Bicistronic DNA Vaccines Simultaneously Encoding HIV, HSV and HPV Antigens Promote CD8+ T Cell Responses and Protective Immunity. PLOS ONE, 8( 8), 10 . doi:10.1371/journal.pone.0071322
NLM
Santana VC, Diniz MO, Cariri FAMO, Ventura AM, Cunha-Neto E, Almeida RR, Campos MA, Lima GK, Ferreira LC de S. Bicistronic DNA Vaccines Simultaneously Encoding HIV, HSV and HPV Antigens Promote CD8+ T Cell Responses and Protective Immunity [Internet]. PLOS ONE. 2013 ; 8( 8): 10 .[citado 2024 maio 03 ] Available from: https://doi.org/10.1371/journal.pone.0071322
Vancouver
Santana VC, Diniz MO, Cariri FAMO, Ventura AM, Cunha-Neto E, Almeida RR, Campos MA, Lima GK, Ferreira LC de S. Bicistronic DNA Vaccines Simultaneously Encoding HIV, HSV and HPV Antigens Promote CD8+ T Cell Responses and Protective Immunity [Internet]. PLOS ONE. 2013 ; 8( 8): 10 .[citado 2024 maio 03 ] Available from: https://doi.org/10.1371/journal.pone.0071322
Artigo de periodico
Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity (2011)
Porchia, Bruna Felicio Milazzotto Maldonado; Diniz, Mariana O.; Cariri, Francisco A. M. O.; Santana, Vinícius C.; Amorim, Jaime H.; Balan, Andrea ; Braga, Catarina Joelma Magalhães; Ferreira, Luís Carlos de Souza
Source: Molecular Pharmaceutics. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PORCHIA, Bruna Felicio Milazzotto Maldonado et al. Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity. Molecular Pharmaceutics, v. 8, n. 6, p. 2320-2330, 2011Tradução . . Disponível em: https://doi.org/10.1021/mp200194s. Acesso em: 03 maio 2024.
APA
Porchia, B. F. M. M., Diniz, M. O., Cariri, F. A. M. O., Santana, V. C., Amorim, J. H., Balan, A., et al. (2011). Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity. Molecular Pharmaceutics, 8( 6), 2320-2330. doi:10.1021/mp200194s
NLM
Porchia BFMM, Diniz MO, Cariri FAMO, Santana VC, Amorim JH, Balan A, Braga CJM, Ferreira LC de S. Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity [Internet]. Molecular Pharmaceutics. 2011 ; 8( 6): 2320-2330.[citado 2024 maio 03 ] Available from: https://doi.org/10.1021/mp200194s
Vancouver
Porchia BFMM, Diniz MO, Cariri FAMO, Santana VC, Amorim JH, Balan A, Braga CJM, Ferreira LC de S. Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity [Internet]. Molecular Pharmaceutics. 2011 ; 8( 6): 2320-2330.[citado 2024 maio 03 ] Available from: https://doi.org/10.1021/mp200194s
Artigo de periodico
Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1 (2005)
Lasaro, Marcio O.; Diniz, Mariana O.; Reyes-Sandoval, Arturo; Ertl, Hildegund C.; Ferreira, Luís Carlos de Souza
Source: Microbes and infection. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LASARO, Marcio O. et al. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1. Microbes and infection, v. 7, p. 1541-1550, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.micinf.2005.05.024. Acesso em: 03 maio 2024.
APA
Lasaro, M. O., Diniz, M. O., Reyes-Sandoval, A., Ertl, H. C., & Ferreira, L. C. de S. (2005). Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1. Microbes and infection, 7, 1541-1550. doi:10.1016/j.micinf.2005.05.024
NLM
Lasaro MO, Diniz MO, Reyes-Sandoval A, Ertl HC, Ferreira LC de S. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1 [Internet]. Microbes and infection. 2005 ; 7 1541-1550.[citado 2024 maio 03 ] Available from: https://doi.org/10.1016/j.micinf.2005.05.024
Vancouver
Lasaro MO, Diniz MO, Reyes-Sandoval A, Ertl HC, Ferreira LC de S. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1 [Internet]. Microbes and infection. 2005 ; 7 1541-1550.[citado 2024 maio 03 ] Available from: https://doi.org/10.1016/j.micinf.2005.05.024

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em